Publications by authors named "Tal Burt"

Claim this Profile
P
Phase 0 trials/ Intra-Target-Microdosing (ITM) and the lung: a review.
Tom M Quinn, Annya M Bruce, Tal Burt, Kevin Dhaliwal

BMC Pulm Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategic, feasibility, economic, and cultural aspects of phase 0 approaches: Is it time to change the drug development process in order to increase productivity?
Tal Burt, Ad F Roffel, Oliver Langer, Kirsten Anderson, Joseph DiMasi

Clin Transl Sci· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 0/microdosing approaches: time for mainstream application in drug development?
Tal Burt, Graeme Young, Wooin Lee, Hiroyuki Kusuhara, Oliver Langer

Nat Rev Drug Discov· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 0, including microdosing approaches: Applying the Three Rs and increasing the efficiency of human drug development.
Tal Burt, Le Thuy Vuong, Elizabeth Baker, Graeme C Young, A Daniel McCartt

Altern Lab Anim· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase-0/microdosing studies using PET, AMS, and LC-MS/MS: a range of study methodologies and conduct considerations. Accelerating development of novel pharmaceuticals through safe testing in humans - a practical guide.
Tal Burt, Christy S John, Jon L Ruckle, Le T Vuong

Expert Opin Drug Deliv· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating Pharmacoproteomics into Early-Phase Clinical Development: State-of-the-Art, Challenges, and Recommendations.
Savita Nandal, Tal Burt

Int J Mol Sci· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knowledge and Perception about Clinical Research Shapes Behavior: Face to Face Survey in Korean General Public.
Yun Jung Choi, Sung-Ho Beck, Woon Yong Kang, Soyoung Yoo, Seong-Yoon Kim, Tal Burt

J Korean Med Sci· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraarterial Microdosing: A Novel Drug Development Approach, Proof-of-Concept PET Study in Rats.
Tal Burt, Douglas C Rouse, Kihak Lee, Huali Wu, Anita T Layton

J Nucl Med· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyroid Autoimmune Antibodies and Major Depressive Disorder in Women.
Johnson Fam, A John Rush, Tal Burt, Edwin Sy Chan, Fahad J Siddiqui

Ann Acad Med Singap· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Research Environment in India: Challenges and Proposed Solutions.
Tal Burt, Pooja Sharma, Savita Dhillon, Mukul Manchanda, Sanjay Mittal

J Clin Res Bioeth· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethics Standards (HRPP) and Public Partnership (PARTAKE) to Address Clinical Research Concerns in India: Moving Toward Ethical, Responsible, Culturally Sensitive, and Community-Engaging Clinical Research.
Tal Burt, Yogendra K Gupta, Nalin Mehta, Nagendra Swamy, Vishwas

J Clin Res Bioeth· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARTAKE survey of public knowledge and perceptions of clinical research in India.
Tal Burt, Savita Dhillon, Pooja Sharma, Danish Khan, Deepa Mv

PLoS One· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microdosing and drug development: past, present and future.
Graham Lappin, Robert Noveck, Tal Burt

Expert Opin Drug Metab Toxicol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomics in early-phase clinical development.
Tal Burt, Savita Dhillon

Pharmacogenomics· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research Question, Study Design and Continuous Research Education and Training Exercises (CREATE) Program.
Tal Burt, Pooja Sharma, Sanjay Mittal

J Clin Prev Cardiol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of duloxetine, escitalopram, and sertraline effects on cytochrome P450 2D6 function in healthy volunteers.
Sheldon H Preskorn, David J Greenblatt, David Flockhart, Yan Luo, Elke S Perloff, Tal Burt

J Clin Psychopharmacol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A placebo-controlled, randomized withdrawal study of sertraline for major depressive disorder in Japan.
Kunitoshi Kamijima, Tal Burt, Guy Cohen, Ichiro Arano, Toshimitsu Hamasaki

Int Clin Psychopharmacol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms.
Aytekin Sir, Russell F D'Souza, Sukru Uguz, Tom George, Simavi Vahip, Tal Burt

J Clin Psychiatry· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A placebo-controlled, randomized withdrawal study of sertraline for panic disorder in Japan.
Kunitoshi Kamijima, Tomifusa Kuboki, Hiroaki Kumano, Tal Burt, Guy Cohen

Int Clin Psychopharmacol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal length of antidepressant trials in late-life depression.
Harold A Sackeim, Steven P Roose, Tal Burt

J Clin Psychopharmacol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender differences in clinical presentation and response to sertraline treatment of generalized anxiety disorder.
Meir Steiner, Christer Allgulander, Arun Ravindran, Hana Kosar, Tal Burt

Hum Psychopharmacol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late onset dysthymic disorder and major depression differ from early onset dysthymic disorder and major depression in elderly outpatients.
D P Devanand, Elizabeth Adorno, Jocelyn Cheng, Tal Burt, G H Gregory H Pelton

J Affect Disord· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety, and tolerability of sertraline in patients with late-life depression and comorbid medical illness.
Javaid I Sheikh, Erin L Cassidy, P Murali Doraiswamy, Ronald M Salomon, Mady Hornig, Tal Burt

J Am Geriatr Soc· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil.
Sanford I Finkel, Jacobo E Mintzer, Maurice Dysken, K R R Krishnan, Tal Burt

Int J Geriatr Psychiatry· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis